Recent Research | Page 75 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Datesort descending Journal Bone Marrow Disease
Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia May 2017 Blood acute myeloid leukemia (AML)
New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes Jun 2017 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)
Standardized High-Sensitivity Flow Cytometry Testing for Paroxysmal Nocturnal Hemoglobinuria in Children with Acquired Bone Marrow Failure Disorders: A Single Center U.S. Study Jun 2017 Cytometry B Clin Cytom paroxysmal nocturnal hemoglobinuria (PNH)
Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents Jun 2017 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy Jun 2017 Br J Haematol myelodysplastic syndromes (MDS)
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy. Jun 2017 Oncotarget myelodysplastic syndromes (MDS)
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Jun 2017 Leukemia myelodysplastic syndromes (MDS)
T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways Jun 2017 J Immunol paroxysmal nocturnal hemoglobinuria (PNH)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond Jun 2017 Semin Hematol
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Jun 2017 Semin Hematol myelodysplastic syndromes (MDS)